Dendrou CA., Cortes A., Shipman L., Evans HG., Attfield KE., Jostins L., Barber T., Kaur G., Kuttikkatte SB., Leach OA., Desel C., Faergeman SL., Cheeseman J., Neville MJ., Sawcer S., Compston A., Johnson AR., Everett C., Bell JI., Karpe F., Ultsch M., Eigenbrot C., McVean G., Fugger L.

Resolving TYK2 locus genotype-to-phenotype differences reveals an immune signaling optimum that may be exploited therapeutically for treating autoimmune diseases.

Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity

Dendrou CA., Cortes A., Shipman L., Evans HG., Attfield KE., Jostins L., Barber T., Kaur G., Kuttikkatte SB., Leach OA., Desel C., Faergeman SL., Cheeseman J., Neville MJ., Sawcer S., Compston A., Johnson AR., Everett C., Bell JI., Karpe F., Ultsch M., Eigenbrot C., McVean G., Fugger L.

DOI

Type

Publisher

Publication Date

Volume